| 摘要 |
Novel compounds according to the formula and pharmaceutically acceptable salts, solvates, or hydrates thereof; wherein each occurrence of A is independently selected from CH or N; X is selected from the group consisting of -CH<SUB>2</SUB>-, -O-, -NH-, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkylamino-, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkylaminocarbonylamino-, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkylcarbonylamino-, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkylsulfonylamino-, phenylsulfonylamino-, carbonyl, -NH-C(O)-, -N(C<SUB>1</SUB>-C<SUB>6</SUB>)alkyl-C(O)-, -S(O)<SUB>y</SUB>- where y is 0, 1 or 2, and; n in -(CH<SUB>2</SUB>)<SUB>n</SUB>- is 1, 2 or 3; and R<SUP>1</SUP>, R<SUP>2</SUP>, and R<SUP>3 </SUP>are as described herein; pharmaceutical compositions that including these compounds, and methods for the treatment of autoimmune disease, inflammation, allergy, transplant rejection, and other circumstances where administration of an immunosuppressive agent is of therapeutic benefit.
|
